Singaraja– The Covid-19 pandemic has had an adverse impact on all sectors of Indonesian people’s lives. One sector that has been significantly affected is the health sector. Covid-19 can threaten the health of various age groups, especially the elderly and people with chronic co-morbidities which in medical terms are called co-morbid.
Diabetes mellitus is the second most common comorbidity in Covid-19 cases, which is 8 percent with a death rate three times that of sufferers in general, so this gets more attention from health workers. Patients with comorbid diabetes mellitus must regularly control their blood glucose levels in an effort to prevent further complications. However, patients are often constrained in carrying out blood glucose monitoring independently due to several reasons, including the difficulty in understanding monitoring results and the low level of compliance of diabetes mellitus patients to carry out controls. What’s more, the Covid-19 pandemic situation has made it more difficult for diabetes patients to consult directly with health workers because diabetes mellitus patients have a greater risk of being infected with Covid-19 and there is a fear of patients having to take control of the hospital during a pandemic.
Responding to this problem, the Undiksha Student Creativity Program (PKM-KC) team consists of
Kadek Edy Sukarma, Putu Krisna Satya Jayadi, I Gede Rama Santika from the Medical Study Program, Kartika Nikova from the Information Systems Study Program, and Ketut Nova Wirya Dinata from the Informatics Engineering Education Study Program tried to prepare a solution.
Under the guidance of Dr. dr. Made Kurnia Widiastuti Giri, S.Ked., M.Kes., this team designed an innovative IoMT-based Smart Serum Glucose Monitor as a health monitoring tool for comorbid diabetes mellitus patients during the Covid-19 pandemic.
Smart Serum Glucose Monitor is a system designed by combining a glucometer based on IoMT (Internet of Medical Things) which is added to a chip with a telemedicine application with various features to be able to periodically detect blood glucose levels and health conditions of comorbid diabetes mellitus patients remotely. Some of the features contained in this system support the practicality and superiority of this tool. First, auto-notification, namely the results of checking blood glucose will be immediately recorded and categorized as high, normal, or low on patient and health worker applications automatically and patients can consult with health workers regarding their health conditions via messages on smartphones. The second feature is a statistical feature that can monitor the development of the patient’s blood glucose levels on a regular basis, the results of which can be statistical. Furthermore, there is a reminder feature that can remind patients to check their blood glucose regularly at their respective residences. Another feature is the security feature using fingerprints which aims to prevent patient data from being manipulated by others. The last feature is emergency support based on location which can provide assistance by searching the nearest hospital or health facility from the user’s location if the patient experiences very bad complications and is in an emergency.
“Implementation of activities for 4 months from June to September starting from designing hardware and applications to testing tools. The results obtained from this trial show the accuracy of the Smart Serum Glucose Monitor tool, which is 98.94 percent with various features that are running well,” explained Team Leader, Edy Sukarma, Tuesday (13/9/2022).
The innovation of the Smart Serum Glucose Monitor is expected to be able to assist health workers in monitoring the development of blood glucose and the health conditions of patients with comorbid diabetes mellitus. (rls)
